Tom

This is not necessary or appropriate - as Matthew has said - placenta is
both! It is important that our solution allows information about another
person to be in an EHR - family history is a good example. We will not link
between peoples EHRs - ever in my opinion.

Cheers, Sam

> -----Original Message-----
> From: Thomas Beale [mailto:thomas at deepthought.com.au]
> Sent: Thursday, 19 December 2002 1:43 AM
> To: Sam Heard
> Cc: openehr-technical at openehr.org
> Subject: Re: [Fwd: RE: Subject of care]
>
>
>
> I think that the only systematic approach is to make a new EHR for each
> genetically distinct individual. This means making an EHR for a foetus
> as soon as anything at all is to be measured about it, and also storing
> the link of this EHR to that of the mother. If the foetus dies in utero
> or is aborted, then its EHR shows this properly as "death" jsut as it
> would be shown in a normal person's record. As for situations where the
> individual's DNA distinctness is not totally clear like the bone marro
> transplant situation, I don't think that is a problem. Observations can
> be made on genetically different material to the patient, in the
> patient's record, as long as these observations relate to the care of
> that patient. E.g. blood tests, other tests made to a sibling for the
> sole purpose of doing a transplant into the patient - should probably go
> into the patient's EHR...
>
> But I do think we need to forget the idea that because a foetus is not
> really a person, it is not a possible subject of an EHR. I think we have
> to work on genetic distinction and distinct organism (whether called
> "human" or not) instead.
>
> thoughts?
>
> - thomas
>
> Sam Heard wrote:
>
>  >Matthew
>  >
>  >Great scenario's
>  >
>  >>1. If prenatal diagnosis is being done by chorionic villus sampling
>  >>(CVS) in a twin pregnancy (which does happen) then it is the placenta
>  >>- or rather the placentas - which are sampled. Each placenta has a
>  >>DNA genotype matching that of the fetus attached to it (ie not the
>  >>mother) as the placenta is an extension of the fetus. If however the
>  >>fetus is an extension of the mother, then are we really saying we
>  >>like the idea that the placentas may have to appear as multiple
>  >>"temporary" organs of the mother, which are different in every
>  >>pregnancy, and which never share her total genotype? A likely outcome
>  >>would be selective termination of one twin (the affected one, on the
>  >>basis of a molecular finding and either a makable or a confidently
>  >>predictable clinical diagnosis) leaving the unaffected one to go to
>  >>term. Thus a part of the mother is diagnosed clinically and
>  >>molecularly, findings which are important for the mother later on, in
>  >>that they'll trigger appropriate care next time around, but which
>  >>*must not* be confused with her own clinical diagnoses or test
>  >>results.
>  >>
>  >
>  >This example is a very good one - it shows that there is a need to
> identify
>  >the fetus over and above its relationship with the mother. I have
> suggested
>  >that we use a local label for this - could be LOCAL:Twin1_2002. - the
>  >relationship for the information is FETUS. The important thing here is
> that
>  >we have the idea of subject of care - a unique identifier (or self)
> and the
>  >relationship.
>  >
>  >The sampling is the taking of a histological sample of a body part - the
>  >subject is the FETUS. There will be a procedure record, a sample and a
>  >histological report - all with the fetus as the subject of care for the
>  >data - in a composition that is part of the mothers EHR. It may be
> copied to
>  >the child's EHR in the future - I have thought about the transform
> required
>  >to do this and it should be relatively easy if the relationship
> of the two
>  >records is stated first.
>  >
>  >>2. Bone marrow transplantation, where it may be necessary to
>  >>distinguish that the post-transplant patient may still have a
>  >>haemoglobin variant, but a different one to the one they were treated
>  >>for, and accordingly no disorder to go with it, but will still be
>  >>genetically as they were before the treatment in every other organ.
>  >>Also the donor was most probably selected from the same family, so
>  >>confidentiality may be slightly different...?
>  >>
>  >
>  >Interesting - who is the subject of care then? I guess this will be
> deduced
>  >from the data - I do not think that we can say the origins of all the
> states
>  >in a person that arise following a donation - at times it may
> be ambiguous
>  >(graft v host).
>  >
>  >We have considered 'donor' to be the relationship - but the person may
> have
>  >a relationship with the person apart from this? I do not think that the
>  >subject of care needs to be the donor then - it can be the family
> member as
>  >it is known who they are. Interesting!
>  >
>  >>It seems to me that we can either organise our concepts to make this
>  >>kind of record easier and more obvious, or we can begin to inbuild
>  >>problems for later on (eg if the fetus is part of the mother, having
>  >>to explain to all our knowledge agents that this might not extend to
>  >>genotypes, or if it does, then by chance rather than biological
>  >>imperative etc...). In the event of one of two fetuses being
>  >>affected, and one pregnancy being terminated, what is the result in
>  >>the record to indicate the original number of conceptions, the fact
>  >>that a genetic risk actually produced a fetus with a prospective
>  >>problem, and the DNA and other data originated in the process of the
>  >>testing of the CVS sample? It would be wrong, I feel, to treat the
>  >>fetus' diagnosis as one of the mother, as confusion here could lead
>  >>to all kinds of erroneous conclusions (one fetus had sickle cell ->
>  >>mother - who is actually just a carrier - has sickle cell...?).
>  >>
>  >
>  >I do believe that we have this covered - the donor example is a bit of a
>  >mind bender but I think the subject of care and relationship
> provides the
>  >solution.
>  >
>  >COmments?
>  >
>  >Cheers, Sam
>  >____________________________________________
>  >Dr Sam Heard
>  >Ocean Informatics, openEHR
>  >Co-Chair, EHR-SIG, HL7
>  >Chair EHR IT-14-2, Standards Australia
>  >Hon. Senior Research Fellow, UCL, London
>  >
>  >105 Rapid Creek Rd
>  >Rapid Creek NT 0810
>  >
>  >Ph: +61 417 838 808
>  >
>  >sam.heard at bigpond.com
>  >
>  >www.openEHR.org
>  >www.HL7.org
>  >__________________________________________
>  >
>  >-
>  >If you have any questions about using this list,
>  >please send a message to d.lloyd at openehr.org
>  >
>  >
>
> --
> ..............................................................
> Deep Thought Informatics Pty Ltd
> mailto:thomas at deepthought.com.au
>
> openEHR - http://www.openEHR.org
> Archetypes - http://www.deepthought.com.au/it/archetypes.html
> Community Informatics -
> http://www.deepthought.com.au/ci/rii/Output/mainTOC.html
> ..............................................................
>
>
>
>
>

-
If you have any questions about using this list,
please send a message to d.lloyd at openehr.org

Reply via email to